Commentary on "Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials"

Research output: Contribution to journal › Comment/debate

Cite this

@article{1279d4ea064746629dc0bcd48ad1de89,

title = "Commentary on {"}Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials{"}",

author = "Sparano, {J. A.}",

year = "2001",

month = jan,

day = "1",

doi = "10.1016/S1526-8209(11)70318-4",

language = "English (US)",

volume = "2",

pages = "37--38",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Commentary on "Results and implications of the Royal Marsden and other tamoxifen chemoprevention trials"

AU - Sparano, J. A.

PY - 2001/1/1

Y1 - 2001/1/1

UR - http://www.scopus.com/inward/record.url?scp=0035004575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035004575&partnerID=8YFLogxK

U2 - 10.1016/S1526-8209(11)70318-4

DO - 10.1016/S1526-8209(11)70318-4

M3 - Comment/debate

AN - SCOPUS:0035004575

VL - 2

SP - 37

EP - 38

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

IS - 1

ER -